These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30830488)

  • 1. ERα upregulates the expression of long non-coding RNA LINC00472 which suppresses the phosphorylation of NF-κB in breast cancer.
    Wang Z; Katsaros D; Biglia N; Shen Y; Loo L; Yu X; Lin H; Fu Y; Chu WM; Fei P; Ni Y; Jia W; Deng X; Qian B; Yu H
    Breast Cancer Res Treat; 2019 Jun; 175(2):353-368. PubMed ID: 30830488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LINC00472 expression is regulated by promoter methylation and associated with disease-free survival in patients with grade 2 breast cancer.
    Shen Y; Wang Z; Loo LW; Ni Y; Jia W; Fei P; Risch HA; Katsaros D; Yu H
    Breast Cancer Res Treat; 2015 Dec; 154(3):473-82. PubMed ID: 26564482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of Forkhead box protein A1 (FOXA1) leads to cancer stem cell-like properties in tamoxifen-resistant breast cancer cells through induction of interleukin-6.
    Yamaguchi N; Nakayama Y; Yamaguchi N
    J Biol Chem; 2017 May; 292(20):8136-8148. PubMed ID: 28270510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic and predictive values of long non-coding RNA LINC00472 in breast cancer.
    Shen Y; Katsaros D; Loo LW; Hernandez BY; Chong C; Canuto EM; Biglia N; Lu L; Risch H; Chu WM; Yu H
    Oncotarget; 2015 Apr; 6(11):8579-92. PubMed ID: 25865225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NF-κB Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor-Positive Breast Cancers.
    Kastrati I; Joosten SEP; Semina SE; Alejo LH; Brovkovych SD; Stender JD; Horlings HM; Kok M; Alarid ET; Greene GL; Linn SC; Zwart W; Frasor J
    Mol Cancer Res; 2020 Jul; 18(7):1018-1027. PubMed ID: 32245803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA1-mimetic compound NSC35446.HCl inhibits IKKB expression by reducing estrogen receptor-α occupancy in the IKKB promoter and inhibits NF-κB activity in antiestrogen-resistant human breast cancer cells.
    Nathan S; Ma Y; Tomita YA; De Oliveira E; Brown ML; Rosen EM
    Breast Cancer Res Treat; 2017 Dec; 166(3):681-693. PubMed ID: 28808806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Non-Coding RNA H19 Acts as an Estrogen Receptor Modulator that is Required for Endocrine Therapy Resistance in ER+ Breast Cancer Cells.
    Basak P; Chatterjee S; Bhat V; Su A; Jin H; Lee-Wing V; Liu Q; Hu P; Murphy LC; Raouf A
    Cell Physiol Biochem; 2018; 51(4):1518-1532. PubMed ID: 30497079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXC1 is involved in ERα silencing by counteracting GATA3 binding and is implicated in endocrine resistance.
    Yu-Rice Y; Jin Y; Han B; Qu Y; Johnson J; Watanabe T; Cheng L; Deng N; Tanaka H; Gao B; Liu Z; Sun Z; Bose S; Giuliano AE; Cui X
    Oncogene; 2016 Oct; 35(41):5400-5411. PubMed ID: 27041579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ERα-miR-575-p27 feedback loop regulates tamoxifen sensitivity in ER-positive Breast Cancer.
    Liu SS; Li Y; Zhang H; Zhang D; Zhang XB; Wang X; Yu Y
    Theranostics; 2020; 10(23):10729-10742. PubMed ID: 32929377
    [No Abstract]   [Full Text] [Related]  

  • 10. The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling.
    Scherbakov AM; Sorokin DV; Tatarskiy VV; Prokhorov NS; Semina SE; Berstein LM; Krasil'nikov MA
    IUBMB Life; 2016 Apr; 68(4):281-92. PubMed ID: 26892736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
    Grabinski N; Möllmann K; Milde-Langosch K; Müller V; Schumacher U; Brandt B; Pantel K; Jücker M
    Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer.
    Bostner J; Alayev A; Berman AY; Fornander T; Nordenskjöld B; Holz MK; Stål O
    Breast Cancer Res Treat; 2018 Feb; 168(1):17-27. PubMed ID: 29128895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-Molecule Sequencing Reveals Estrogen-Regulated Clinically Relevant lncRNAs in Breast Cancer.
    Jonsson P; Coarfa C; Mesmar F; Raz T; Rajapakshe K; Thompson JF; Gunaratne PH; Williams C
    Mol Endocrinol; 2015 Nov; 29(11):1634-45. PubMed ID: 26426411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation independent eIF4E translational reprogramming of selective mRNAs determines tamoxifen resistance in breast cancer.
    Gong C; Tsoi H; Mok KC; Cheung J; Man EPS; Fujino K; Wong A; Lam EWF; Khoo US
    Oncogene; 2020 Apr; 39(15):3206-3217. PubMed ID: 32066877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF-kappaB and estrogen receptor alpha interactions: Differential function in estrogen receptor-negative and -positive hormone-independent breast cancer cells.
    Gionet N; Jansson D; Mader S; Pratt MA
    J Cell Biochem; 2009 Jun; 107(3):448-59. PubMed ID: 19350539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. circRNA-SFMBT2 orchestrates ERα activation to drive tamoxifen resistance in breast cancer cells.
    Li Z; Li Y; Han D; Wang X; Li C; Chen T; Li W; Liang Y; Luo D; Chen B; Wang L; Zhao W; Yang Q
    Cell Death Dis; 2023 Jul; 14(7):482. PubMed ID: 37524698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HOXB13 mediates tamoxifen resistance and invasiveness in human breast cancer by suppressing ERα and inducing IL-6 expression.
    Shah N; Jin K; Cruz LA; Park S; Sadik H; Cho S; Goswami CP; Nakshatri H; Gupta R; Chang HY; Zhang Z; Cimino-Mathews A; Cope L; Umbricht C; Sukumar S
    Cancer Res; 2013 Sep; 73(17):5449-58. PubMed ID: 23832664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA MIAT is estrogen-responsive and promotes estrogen-induced proliferation in ER-positive breast cancer cells.
    Li Y; Jiang B; Wu X; Huang Q; Chen W; Zhu H; Qu X; Xie L; Ma X; Huang G
    Biochem Biophys Res Commun; 2018 Sep; 503(1):45-50. PubMed ID: 29792859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wilms' tumor 1 suppressor gene mediates antiestrogen resistance via down-regulation of estrogen receptor-alpha expression in breast cancer cells.
    Han Y; Yang L; Suarez-Saiz F; San-Marina S; Cui J; Minden MD
    Mol Cancer Res; 2008 Aug; 6(8):1347-55. PubMed ID: 18708366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA MEG3 inhibits breast cancer growth via upregulating endoplasmic reticulum stress and activating NF-κB and p53.
    Zhang Y; Wu J; Jing H; Huang G; Sun Z; Xu S
    J Cell Biochem; 2019 Apr; 120(4):6789-6797. PubMed ID: 30556250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.